Education
About Us
Working with TipRanks
Follow Us
Paxman AB (SE:PAX)
:PAX
PAX Stock Chart & Stats
kr54.60
-kr1.20(-1.81%)
At close: 4:00 PM EST
kr54.60
-kr1.20(-1.81%)
Day’s Range― - ―
52-Week Rangekr59.80 - kr85.80
Previous CloseN/A
Volume3.13K
Average Volume (3M)100.37K
Market Cap
kr1.27B
Enterprise Valuekr1.66B
Total Cash (Recent Filing)kr129.53M
Total Debt (Recent Filing)kr10.72M
Price to Earnings (P/E)196.8
Beta0.03
Next Earnings
Feb 27, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding23,273,417
10 Day Avg. Volume41,338
30 Day Avg. Volume100,373
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)7.61
Price to Sales (P/S)4.93
P/FCF Ratio78.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Paxman AB News
PAX FAQ
What was Paxman AB’s price range in the past 12 months?
Paxman AB lowest stock price was kr59.80 and its highest was kr85.80 in the past 12 months.
What is Paxman AB’s market cap?
Paxman AB’s market cap is kr1.27B.
When is Paxman AB’s upcoming earnings report date?
Paxman AB’s upcoming earnings report date is Feb 27, 2026 which is in 71 days.
How were Paxman AB’s earnings last quarter?
Paxman AB released its earnings results on Nov 14, 2025. The company reported kr0.1 earnings per share for the quarter, beating the consensus estimate of kr0 by kr0.1.
Is Paxman AB overvalued?
According to Wall Street analysts Paxman AB’s price is currently Overvalued.
Does Paxman AB pay dividends?
Paxman AB does not currently pay dividends.
What is Paxman AB’s EPS estimate?
Paxman AB’s EPS estimate is 0.
How many shares outstanding does Paxman AB have?
Paxman AB has 23,273,417 shares outstanding.
What happened to Paxman AB’s price movement after its last earnings report?
Paxman AB reported an EPS of kr0.1 in its last earnings report, beating expectations of kr0. Following the earnings report the stock price went down -6.192%.
Which hedge fund is a major shareholder of Paxman AB?
Currently, no hedge funds are holding shares in SE:PAX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Paxman AB
Paxman AB (PAX) is a Swedish medical technology company specializing in solutions designed to alleviate the side effects of chemotherapy, particularly hair loss. The company operates primarily in the healthcare sector and is known for its innovative scalp cooling systems, which help cancer patients retain their hair during chemotherapy treatments. Paxman’s core product offerings include the Paxman Scalp Cooling System, which utilizes a patented technology that circulates cooled liquid through a cap worn on the patient’s head, minimizing hair loss and improving the overall quality of life for patients undergoing cancer treatments.
PAX Earnings Call
Q3 2025
0:00 / 0:00